ALB and sarcopenia: In the flowchart for nutritional therapy in the Japanese guidelines for the treatment of cirrhosis 2020, patients are initially screened for serum albumin levels, Child-Pugh classifications, and the presence of sarcopenia (using JSH criteria [3]), and even if none of these are met, in patients with a low BMI (<18.5 kg/m2), nutritional dietary guidance and general enteral nutrition are recommended, taking into account the risk of sarcopenia.